Cargando…
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
BACKGROUND: Progressive multifocal leukoencephalopathy (PML) is a rare and often lethal brain disorder caused by the common, typically benign polyomavirus 2, also known as JC virus (JCV). In a small percentage of immunosuppressed individuals, JCV is reactivated and infects the brain, causing devasta...
Autores principales: | Hatchwell, Eli, Smith, Edward B., Jalilzadeh, Shapour, Bruno, Christopher D., Taoufik, Yassine, Hendel-Chavez, Houria, Liblau, Roland, Brassat, David, Martin-Blondel, Guillaume, Wiendl, Heinz, Schwab, Nicholas, Cortese, Irene, Monaco, Maria Chiara, Imberti, Luisa, Capra, Ruggero, Oksenberg, Jorge R., Gasnault, Jacques, Stankoff, Bruno, Richmond, Todd A., Rancour, David M., Koralnik, Igor J., Hanson, Barbara A., Major, Eugene O., Chow, Christina R., Eis, Peggy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795231/ https://www.ncbi.nlm.nih.gov/pubmed/36588876 http://dx.doi.org/10.3389/fneur.2022.1016377 |
Ejemplares similares
-
Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
por: Eis, Peggy S., et al.
Publicado: (2020) -
Efficacy of Recombinant Human Interleukin 7 in a Patient With Severe Lymphopenia-Related Progressive Multifocal Leukoencephalopathy
por: Gasnault, Jacques, et al.
Publicado: (2014) -
Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy
por: Dekeyser, Manon, et al.
Publicado: (2017) -
Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy
por: Gasnault, Jacques, et al.
Publicado: (2011) -
B Cells and Progressive Multifocal Leukoencephalopathy: Search for the Missing Link
por: Durali, Deniz, et al.
Publicado: (2015)